DRIEHAUS CAPITAL MANAGEMENT LLC
Institutional investor · Portfolio as of Q2 2022
Top Holdings352 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/ | 3.8M | $310.3M | 5.0% | $54.00 | +46.17% | 14 qtrssince 2019-Q1 | Increased 60 |
XENON PHARMACEUTICALS INC | 4.4M | $133.6M | 2.2% | $25.67 | +20.36% | 10 qtrssince 2020-Q1 | Increased 66 |
CAMECO CORP | 5M | $104.5M | 1.7% | $23.15 | -6.92% | 4 qtrssince 2021-Q3 | Decreased 0 |
CRINETICS PHARMACEUTICALS IN | 5.5M | $102.1M | 1.7% | $20.88 | -13.80% | 9 qtrssince 2020-Q2 | Increased 52 |
WILLSCOT HOLDINGS CORP | 2.5M | $81.4M | 1.3% | $35.31 | -9.23% | 4 qtrssince 2021-Q3 | Increased 51 |
HDFC BANK LTD-ADR | 1.4M | $77.6M | 1.3% | $28.04 | -6.26% | 14 qtrssince 2019-Q1 | Decreased 0 |
PFIZER INC | 1.4M | $75.3M | 1.2% | $42.17 | -36.29% | 3 qtrssince 2021-Q4 | Increased 56 |
KINSALE CAP GROUP INC | 315,947 | $72.6M | 1.2% | $229.89 | -3.74% | 3 qtrssince 2021-Q4 | Increased 56 |
NEWMONT MINING CORP | 1.2M | $72.2M | 1.2% | $67.54 | -17.45% | 2 qtrssince 2022-Q1 | Increased 60 |
ICICI BANK LTD-SPON ADR | 3.9M | $70M | 1.1% | $13.66 | +25.92% | 14 qtrssince 2019-Q1 | Decreased 0 |
CHART INDS INC | 395,154 | $66.1M | 1.1% | $132.41 | +20.88% | 11 qtrssince 2019-Q4 | Increased 59 |
CYTOKINETICS INC | 1.6M | $64.7M | 1.0% | $12.27 | +297.29% | 13 qtrssince 2019-Q2 | Decreased 0 |
INSPIRE MED SYS INC | 327,799 | $59.9M | 1.0% | $162.45 | +15.60% | 14 qtrssince 2019-Q1 | Increased 43 |
FTI CONSULTING INC | 329,108 | $59.5M | 1.0% | $176.85 | 0.00% | 1 qtr | New 57 |
LANTHEUS HOLDINGS INC | 876,081 | $57.8M | 0.9% | $56.95 | +12.75% | 2 qtrssince 2022-Q1 | Increased 47 |
HALOZYME THERAPEUTICS INC | 1.3M | $56.4M | 0.9% | $39.23 | +15.42% | 10 qtrssince 2020-Q1 | Increased 58 |
MGP INGREDIENTS INC NEW | 552,976 | $55.3M | 0.9% | $86.25 | +9.59% | 5 qtrssince 2021-Q2 | Increased 67 |
ATI INC | 2.4M | $54M | 0.9% | $26.53 | -15.52% | 2 qtrssince 2022-Q1 | Increased 51 |
CELSIUS HOLDINGS INC | 813,578 | $53.1M | 0.9% | $13.82 | +55.61% | 9 qtrssince 2020-Q2 | Increased 52 |
RELAY THERAPEUTICS INC | 3.1M | $51.8M | 0.8% | $35.80 | -53.10% | 8 qtrssince 2020-Q3 | Decreased 0 |
DRIEHAUS CAPITAL MANAGEMENT LLC manages $6.2B across 352 positions as of Q2 2022. Top holdings: TSM (5.0%), XENE (2.2%), CCJ (1.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.
Active quarter - 92 new positions, 117 exits, 125 increased. Top move: MGPI (INCREASED, conviction 67). Portfolio: $6.2B across 352 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer